E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/10/2013 in the Prospect News PIPE Daily.

Merus Labs concludes C$4.61 million private placement of common stock

Proceeds to be used for debt repayment and general corporate purposes

By Devika Patel

Knoxville, Tenn., June 10 - Merus Labs International Inc. said it completed a C$4.61 million private placement of stock. The deal priced for C$4.58 million on June 3.

The company sold 7,678,034 common shares at C$0.60 per share. The price per share is identical to the May 31 closing share price.

A 6% finder's fee was paid to PowerOne Capital Markets Ltd.

Proceeds will be used for debt repayment and general corporate purposes.

The specialty pharmaceutical company is based in Toronto.

Issuer:Merus Labs International Inc.
Issue:Common shares
Amount:C$4,606,820
Shares:7,678,034
Price:C$0.60
Warrants:No
Pricing date:June 3
Settlement date:June 10
Stock symbol:Toronto: MSL
Stock price:C$0.60 at close May 31
Market capitalization:C$27.33 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.